Today's Hospitalist

JUNE 7, 2025

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. ” Phyllis Maguire has been Executive Editor of Today’s Hospitalist since 2006. Based in Bucks County, Pa.,

Hospital 66

Hospital Management Diabetes Patients 66

Permanente Medicine

JUNE 3, 2025

I joined SCPMG straight from residency in 2006. I think sometimes we don’t necessarily realize the importance in the role that each of us individually as physicians can have with patients both within the exam room but also globally. Let’s say a diabetic comes in and they’re on metformin.

IT 52

IT Patient-Centered Patients Medical 52

GeriPal

MAY 1, 2025

There was some at the time, which was 2006 so also, it’s been a while since the guidance has been updated and other guidance for other viral infections like hepatitis B and C. I mean, you know, you mentioned diabetes. Eric 26:39 But I’m also hearing that 1 out of 10 newly diagnosed cases are not those individuals.

Primary Care 96

Primary Care IT Clinic Provider 96